London, April 30, 2026, 18:06 BST
- Thursday saw Jefferies submit another UK takeover-code filing for JTC, adding to a recent streak of dealing disclosures tied to the Permira-led all-cash offer.
- JTC was changing hands at 1,311p to 1,312p—just under the agreed 1,340p offer price—keeping a narrow spread between the market and the deal.
- Final court approvals and a few other outstanding conditions remain before the buyout can wrap up, as planned, in the third quarter.
Jefferies International has revealed new trades and holdings in JTC Plc, putting the London-listed professional services firm back in the spotlight as Permira’s take-private bid nears completion. According to Thursday’s Rule 8.5 disclosure, filed by an exempt principal trader as required under the UK Takeover Code, Jefferies reported a 1.711% interest in JTC and a 1.701% short position as of April 29.
This comes into play now since JTC finds itself well into an offer period. According to the Takeover Panel’s disclosure table, JTC is tagged as the offeree, with Papilio Bidco Limited—tied to Permira Advisers—listed as the offeror. That triggers reporting obligations: anyone holding positions over certain thresholds has to disclose their stakes and any relevant trades.
JTC shares remain just under the cash offer, hovering near but not reaching the mark. AJ Bell’s Thursday figures put the stock at 1,311p on the sell side and 1,312p to buy—flat for the session, after closing previously at 1,312p. Market cap sits around £2.23 billion. With a cash bid locked in at 1,340p per share, investors are still factoring in the risk that comes with timing, regulatory sign-off, and deal completion.
The same rapid-fire trading pops up elsewhere in disclosure filings. Barclays, in a Form 8.3 dated April 29, reported a 2.90% long position in JTC and short bets totaling 2.91% after trades on April 28—a pattern mirrored in other filings. Anyone with at least a 1% stake in relevant securities needs to submit a Form 8.3.
Tudor Investment Corporation turned in a Form 8.3, showing cash-settled derivative interests at 2.3656% and a modest short—just 0.02%. These cash-settled derivatives track the share price but typically pay out in cash, not stock.
Back in November, Permira’s Papilio Bidco cut a deal to acquire JTC, offering 1,340p per share in cash. The offer valued JTC’s equity at around £2.3 billion, with an implied enterprise value coming in near £2.7 billion. At the time, Reuters noted that the offer price was close to 50% higher than JTC’s closing level on Aug. 13, just before Permira’s first approach.
JTC is still pointing to a third-quarter finish in its filings. Back in February, CEO Nigel Le Quesne called the shareholder backing for the deal “overwhelming”—99.97% voted yes, he said—and confirmed they’re targeting completion in Q3 2026. Investegate
The company hasn’t paused its public disclosures as the deal hangs in the air. JTC’s full-year numbers released April 7 put 2025 revenue at £381.9 million, up 25.1%. Underlying EBITDA climbed 22.4% to £124.5 million, while new business wins surged 21.8% to a record £43.5 million.
Permira calls the acquisition a platform play in fund admin, corporate, and trust services. “Accelerate growth”—that’s the goal, according to Robin Bell-Jones, partner and head of London at Permira, in the official release. The plan: back JTC on selective acquisitions. For JTC, CEO Le Quesne points to “financial firepower” from the tie-up, targeting more M&A and a push into AI. Investegate
The bid is part of a wider push for scale. Private capital in fund administration and corporate services has already shifted around players like Alter Domus and IQ-EQ; Cinven snapped up a majority stake in Alter Domus for €4.9 billion, and Reuters said this year that Astorg was considering selling IQ-EQ at a price topping €4 billion.
Still, the deal hasn’t crossed the finish line. According to the scheme document, it’s all contingent on meeting certain conditions and getting the final court sign-off. The sanction hearing is penciled in for Q3 2026, while the long-stop date sits at Nov. 10, 2026, unless that gets pushed back. Any holdup or unmet condition could blow out the spread, forcing investors to go back to valuing JTC based solely on its own earnings and future acquisitions.
The tape’s acting like a merger-arb setup here—tight price shifts, strict disclosures, and shares stuck right below the bid. Any real news will probably hinge on the regulatory and court calendar, rather than anything showing up in daily dealing forms.
